Methods and compositions for measuring Wnt activation and for treating Wntrelated cancers

Details for Australian Patent Application No. 2008324203 (hide)

Owner Novartis AG

Inventors Cheung, Atwood; Cong, Feng

Agent Davies Collison Cave

Pub. Number AU-A-2008324203

PCT Pub. Number WO2009/059994

Priority 60/985,454 05.11.07 US

Filing date 5 November 2008

Wipo publication date 14 May 2009

International Classifications

A61K 31/00 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 April 2010 PCT application entered the National Phase

  PCT publication WO2009/059994 Priority application(s): WO2009/059994

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008324204-Buffer status reporting system and method

2008324194-Method and apparatus for cooling and liquefying a hydrocarbon stream